However, despite the demonstrated effectiveness of some newly developed MTH1 inhibitor drugs, the potential efficacy in targeting MTH1 to treat cancer remains controversial and may depend on the tumor properties (Warpman Berglund et al., 2016; Yin and Chen, 2020). The gene discussed is NUDT1; the disease is cancer.